DK0750501T3 - Farmaceutisk kombinationspræparat til hormonal kontraception - Google Patents

Farmaceutisk kombinationspræparat til hormonal kontraception

Info

Publication number
DK0750501T3
DK0750501T3 DK95913171T DK95913171T DK0750501T3 DK 0750501 T3 DK0750501 T3 DK 0750501T3 DK 95913171 T DK95913171 T DK 95913171T DK 95913171 T DK95913171 T DK 95913171T DK 0750501 T3 DK0750501 T3 DK 0750501T3
Authority
DK
Denmark
Prior art keywords
hormone
preparation
pct
estrogen
daily
Prior art date
Application number
DK95913171T
Other languages
Danish (da)
English (en)
Inventor
Bernd Duesterberg
Ursula Lachnit
Juergen Spona
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6514578&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0750501(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of DK0750501T3 publication Critical patent/DK0750501T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
DK95913171T 1994-03-30 1995-03-30 Farmaceutisk kombinationspræparat til hormonal kontraception DK0750501T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4411585A DE4411585A1 (de) 1994-03-30 1994-03-30 Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
PCT/EP1995/001190 WO1995026730A1 (de) 1994-03-30 1995-03-30 Pharmazeutisches kombinationspräparat zur hormonalen kontrazeption

Publications (1)

Publication Number Publication Date
DK0750501T3 true DK0750501T3 (da) 2002-12-23

Family

ID=6514578

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95913171T DK0750501T3 (da) 1994-03-30 1995-03-30 Farmaceutisk kombinationspræparat til hormonal kontraception

Country Status (25)

Country Link
US (1) US5756490A (ru)
EP (1) EP0750501B1 (ru)
JP (1) JPH09511243A (ru)
KR (1) KR100352571B1 (ru)
CN (1) CN1108800C (ru)
AT (1) ATE222494T1 (ru)
AU (1) AU2073595A (ru)
BG (1) BG63192B1 (ru)
BR (1) BR9507251A (ru)
CA (1) CA2186739A1 (ru)
CZ (1) CZ291698B6 (ru)
DE (2) DE4411585A1 (ru)
DK (1) DK0750501T3 (ru)
ES (1) ES2181770T3 (ru)
FI (1) FI963831A (ru)
HU (1) HUT75521A (ru)
NO (1) NO964089L (ru)
NZ (1) NZ282824A (ru)
PL (1) PL316569A1 (ru)
PT (1) PT750501E (ru)
RO (1) RO118375B1 (ru)
RU (1) RU2165258C2 (ru)
SK (1) SK124396A3 (ru)
UA (1) UA41401C2 (ru)
WO (1) WO1995026730A1 (ru)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
ES2218556T3 (es) * 1994-11-22 2004-11-16 Balance Pharmaceuticals, Inc. Metodos de contracepcion.
DE19513662A1 (de) * 1995-04-08 1996-10-10 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
AU726283B2 (en) * 1995-06-28 2000-11-02 Schering Aktiengesellschaft Pharmaceutical combined preparations, kit and method for hormonal contraception
DE19525017A1 (de) 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
US5747480A (en) * 1996-05-08 1998-05-05 American Home Products Corporation Oral contraceptive
WO1997041868A1 (en) * 1996-05-08 1997-11-13 American Home Products Corporation Oral contraceptive
WO1998004268A1 (en) * 1996-07-26 1998-02-05 American Home Products Corporation Oral contraceptive
US6451778B1 (en) 1996-07-26 2002-09-17 Wyeth Oral contraceptive
AU3888697A (en) * 1996-07-26 1998-02-20 American Home Products Corporation Progestin/estrogen oral contraceptive
ATE271386T1 (de) * 1996-07-26 2004-08-15 Wyeth Corp Orale einstufige empfängnisverhütungsmethode und kombinationspräparat das gestagen und estrogen enthält
US5858405A (en) * 1996-07-26 1999-01-12 American Home Products Corporation Oral contraceptive
US6479475B1 (en) 1996-07-26 2002-11-12 Wyeth Oral contraceptive
US5888543A (en) * 1996-07-26 1999-03-30 American Home Products Corporation Oral contraceptives
US5898032A (en) * 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
EP2305267A3 (en) 1999-08-31 2011-08-17 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
DK1380301T3 (da) * 1999-08-31 2009-04-20 Bayer Schering Pharma Ag Farmaceutisk sammensætning af ethinylestradiol og drospirenon til anvendelse som svangerskabsforebyggende middel
CA2382426C (en) * 1999-08-31 2006-02-28 Schering Aktiengesellschaft Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
SI1453521T1 (sl) * 2001-12-05 2013-11-29 Teva Women's Health, Inc. Oralni kontraceptiki za preprečevanje nosečnosti in zmanjševanje predmenstrualne simptomatike
RU2403046C2 (ru) * 2003-07-16 2010-11-10 Тева Вимен'С Хелс, Инк. Способы гормонального лечения с применением контрацептивных режимов с непрерывным введением эстрогена
WO2005032558A1 (en) * 2003-10-01 2005-04-14 Janssen Pharmaceutica N.V. Extended triphasic contraceptive regimens
EP1535618A1 (en) * 2003-11-26 2005-06-01 Schering Aktiengesellschaft Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions
US20050113350A1 (en) * 2003-11-26 2005-05-26 Bernd Duesterberg Extended use combination comprising estrogens and progestins
US20070111975A1 (en) 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
US7704984B2 (en) * 2005-04-22 2010-04-27 Warner Chilcott Company, Llc Extended estrogen dosing contraceptive regimen
ES2558030T3 (es) * 2006-03-02 2016-02-01 Warner Chilcott Company, Llc Método anticonceptivo oral multifásico de ciclo prolongado
US11376263B2 (en) 2020-10-08 2022-07-05 Fortress Biotech, Inc. Cyproterone acetate compositions and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6615481A (ru) * 1966-11-02 1968-05-03
US3639600A (en) * 1969-08-28 1972-02-01 Upjohn Co Process of establishing cyclicity in a human female
US4921843A (en) * 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
IE71203B1 (en) * 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
DE4104385C1 (ru) * 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich

Also Published As

Publication number Publication date
WO1995026730A1 (de) 1995-10-12
BR9507251A (pt) 1997-09-02
HUT75521A (en) 1997-05-28
CN1108800C (zh) 2003-05-21
NO964089L (no) 1996-11-07
BG63192B1 (bg) 2001-06-29
EP0750501B1 (de) 2002-08-21
MX9604440A (es) 1997-07-31
PL316569A1 (en) 1997-01-20
AU2073595A (en) 1995-10-23
FI963831A0 (fi) 1996-09-25
UA41401C2 (ru) 2001-09-17
DE4411585A1 (de) 1995-10-05
CN1159161A (zh) 1997-09-10
ES2181770T3 (es) 2003-03-01
CZ291698B6 (cs) 2003-05-14
BG100940A (en) 1998-03-31
DE59510333D1 (de) 2002-09-26
KR100352571B1 (ko) 2003-01-06
NZ282824A (en) 1998-07-28
JPH09511243A (ja) 1997-11-11
CA2186739A1 (en) 1995-10-12
FI963831A (fi) 1996-11-29
CZ287996A3 (en) 1997-02-12
US5756490A (en) 1998-05-26
ATE222494T1 (de) 2002-09-15
RO118375B1 (ro) 2003-05-30
EP0750501A1 (de) 1997-01-02
RU2165258C2 (ru) 2001-04-20
NO964089D0 (no) 1996-09-27
PT750501E (pt) 2003-01-31
HU9602657D0 (en) 1996-11-28
SK124396A3 (en) 1997-05-07

Similar Documents

Publication Publication Date Title
DK0750501T3 (da) Farmaceutisk kombinationspræparat til hormonal kontraception
PT835114E (pt) Preparado de combinacao farmaceutico kit e metodo para contracepcao hormonal
DE59205986D1 (de) Ovulationshemmendes Mittel zur hormonalen Kontrazeption
NO974630L (no) Farmasöytisk kombinasjonspreparat for hormonell antikonsepsjon
Van Santen et al. Interception II: postcoital low-dose estrogens and norgestrel combination in 633 women
WO1994002103A3 (de) Ovulationshemmendes mittel zur hormonalen kontrazeption